Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

Cross Asset Strategy

<ul><li>Technically, the SET Index is expected to move sideways, with the support at 1,286/1,281 points and the resistance at 1,301/1,309 points (10-day EMA).</li><li>We maintain our recommendation that investors wait to do speculative buying when there is a new buy signal.</li><li>In-line readings would increase the likelihood of the Fed cutting interest rates at its September meeting.</li></ul>

Technically, the SET Index is expected to move sideways, with the support at 1,286/1,281 points and the resistance at 1,301/1,309 points (10-day EMA).We maintain our recommendation that investors wait to do speculative buying when there is a new buy signal.In-line readings would increase the likelihood of the Fed cutting interest rates at its September meeting.

Keep a Close Watch on US Inflation and Thai Corporate Earnings

Equity Bottom-Up

<ul><li>Technically, the SET Index is expected to move sideways, with the resistance at 1,375/1,380 points and the support at 1,357/1,352 points.</li><li>The consensus expects the labor market to slacken amid potential declines in inflation.</li><li>We recommend dividend plays: ADVANC, INTUCH and WHAUP.</li></ul>

Technically, the SET Index is expected to move sideways, with the resistance at 1,375/1,380 points and the support at 1,357/1,352 points.The consensus expects the labor market to slacken amid potential declines in inflation.We recommend dividend plays: ADVANC, INTUCH and WHAUP.

United States

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant  rejection, and psychiatric disorders.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bristol Myers Squibb Co (BMY US)

Keep a Close Watch on US Inflation and Thai Corporate Earnings

Technically, the SET Index is expected to move sideways, with the support at 1,286/1,281 points and the resistance at 1,301/1,309 points (10-day...

Krungthai XSpring

Keep a Close Watch on US Employment Data

Technically, the SET Index is expected to move sideways, with the resistance at 1,375/1,380 points and the support at 1,357/1,352 points. The...

Krungthai XSpring

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)